Day: July 23, 2021

NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) — Outbrain Inc. (“Outbrain”), announced today the pricing of its initial public offering of 8,000,000 shares of common stock at a price to the public of $20.00 per share. The gross proceeds to Outbrain from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be approximately $160 million. The shares are expected to begin trading on the Nasdaq Global Market on July 23, 2021 under the symbol “OB.” The offering is expected to close on July 27, 2021, subject to customary closing conditions. In addition, the underwriters have been granted a 30-day option to pursue an additional 1,200,000 shares of common stock from Outbrain at the initial public offering price, less underwriting discounts and commissions. Citigroup, Jefferies, Barclays,...

BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 9,090,910 shares of common stock of the Company, at a price to the public of $0.55 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about July 27, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company has granted to the underwriter a...

– Fourth quarter 2020 adjusted sales1 CDN $28.6 million, an increase of 290% over the third quarter– Fourth quarter 2020 revenue of CDN $15.7 million, an increase of 158% over the third quarter– Full Year 2020 adjusted sales1 $37.8 million and Revenue at $23.3 million TORONTO, July 22, 2021 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to report fourth quarter and full year 2020 financial results and is providing certain full year 2020 financial results and select subsequent events. The Company will be filing its 2020 audited financial statements and related Management’s Discussion and Analysis (“MD&A”) today. Management Commentary Brad Rogers, CEO and Chairman stated, “We set out at the beginning of 2020 with a three-year plan...

New safety and efficacy data from both retrospective and prospective studies of the OMNI Surgical System and a prospective study of the TearCare System to be presented MENLO PARK, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the underlying causes of the world’s most prevalent eye diseases, today announced that data from multiple retrospective and prospective clinical studies of the OMNI® Surgical System and TearCare® System will be presented at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. The in-person conference will take place July 23-27 in Las Vegas. A total of five papers have been accepted for presentation. Details of the presentations are as follows (all times are Pacific Daylight Time...